Literature DB >> 1835572

Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells.

Y Nishino1, M Kishi, M Sumiya, K Ogawa, A Adachi, K Maotani-Imai, S Kato, K Hirai, K Ikuta.   

Abstract

A series of human immunodeficiency virus type 1 (HIV-1) mutants in vif, vpr, vpu, and nef were constructed from an infectious plasmid (pNL 432) containing the full-length HIV-1 DNA by frameshift mutations. The capacities for replication and cell killing of these mutant viruses were examined in a clonal cell line (M 10) isolated from HTLV-I-transformed MT-4 cells. In all cases, the mutant viruses replicated, expressed HIV-1 antigens, and induced drastic cytopathic effects. However, some M 10 cells survived infection with vif, vpr, and vpu mutant viruses and became persistently HIV-1-infected, whereas no cells survived infection with the nef mutant as well as the wild-type virus. The HIV-1 particles produced from the surviving cells after infection with the vif, vpr, or vpu mutant viruses were fully replicative in M 10 cells without apparent cytopathic effects.

Entities:  

Mesh:

Year:  1991        PMID: 1835572     DOI: 10.1007/bf01310474

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

Authors:  J Sodroski; W C Goh; C Rosen; A Tartar; D Portetelle; A Burny; W Haseltine
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

2.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Amplification of human immuno-deficiency virus production from a virus-producing cell line in culture at high cell density.

Authors:  K Ikuta; H Imai; S Ueda; S Suehiro; N Yamamoto; S Kato
Journal:  Jpn J Cancer Res       Date:  1987-07

5.  Functional role of human immunodeficiency virus type 1 vpu.

Authors:  E F Terwilliger; E A Cohen; Y C Lu; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  The sor gene of HIV-1 is required for efficient virus transmission in vitro.

Authors:  A G Fisher; B Ensoli; L Ivanoff; M Chamberlain; S Petteway; L Ratner; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1987-08-21       Impact factor: 47.728

7.  Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens.

Authors:  K Ikuta; C Morita; S Miyake; T Ito; M Okabayashi; K Sano; M Nakai; K Hirai; S Kato
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

8.  Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin.

Authors:  K Ikuta; R B Luftig
Journal:  Virology       Date:  1986-10-15       Impact factor: 3.616

9.  A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion.

Authors:  M Somasundaran; H L Robinson
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

10.  Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus.

Authors:  A Adachi; S Koenig; H E Gendelman; D Daugherty; S Gattoni-Celli; A S Fauci; M A Martin
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

View more
  9 in total

Review 1.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells.

Authors:  M Kameoka; T Kimura; Y H Zheng; S Suzuki; K Fujinaga; R B Luftig; K Ikuta
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1.

Authors:  E Yuste; C López-Galíndez; E Domingo
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.

Authors:  Y L Lu; P Spearman; L Ratner
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

5.  Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells.

Authors:  Diane L Bolton; Michael J Lenardo
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

6.  Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.

Authors:  P Sova; D J Volsky
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells.

Authors:  M Kishi; Y H Zheng; M K Bahmani; K Tokunaga; H Takahashi; M Kakinuma; P K Lai; M Nonoyama; R B Luftig; K Ikuta
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  14-3-3 theta binding to cell cycle regulatory factors is enhanced by HIV-1 Vpr.

Authors:  Diane L Bolton; Robert A Barnitz; Keiko Sakai; Michael J Lenardo
Journal:  Biol Direct       Date:  2008-04-29       Impact factor: 4.540

9.  Persistently human immunodeficiency virus type 1-infected T cell clone expressing only doubly spliced mRNA exhibits reduced cell surface CD4 expression.

Authors:  M Kishi; Y Nishino; K Ohki; T Kimura; K Ikuta
Journal:  Jpn J Cancer Res       Date:  1993-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.